Medical Science Liaison

UltraGenix Pharmaceutical
JapanPosted 2 March 2026

Job Description

<div class="content-intro"><div><strong>Why Join Us?</strong></div> <div> </div> <div><em>Be a hero for our rare disease patients</em></div> <div><em> </em></div> <div>At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them. </div> <div> </div> <div>Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth – so employees can thrive in all areas of their lives, in and outside of work. Ultimately, we want to be an organization where we would be proud for our family, friends and children to work.</div> <div> </div> <div>If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and personally, come join our team<em>. </em></div></div><h3 style="text-align: left;"><strong>Position Summary:</strong></h3> <p style="text-align: left;"><strong><em>ultra</em></strong><em>focused – Work together to fearlessly uncover new possibilities</em></p> <p style="text-align: left;"><span class="TextRun SCXW99903740 BCX8" lang="JA-JP" data-contrast="auto"><span class="NormalTextRun SCXW99903740 BCX8">メディカルサイエンスリエゾン(</span></span><span class="TextRun SCXW99903740 BCX8" lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW99903740 BCX8">Medical Science </span><span class="NormalTextRun SpellingErrorV2Themed SCXW99903740 BCX8">Liaison</span><span class="NormalTextRun SpellingErrorV2Themed SCXW99903740 BCX8">:</span><span class="NormalTextRun SpellingErrorV2Themed SCXW99903740 BCX8">MSL</span><span class="NormalTextRun SCXW99903740 BCX8">)</span></span><span class="TextRun SCXW99903740 BCX8" lang="JA-JP" data-contrast="auto"><span class="NormalTextRun SCXW99903740 BCX8">は、メディカルディレクターおよびフィールドメディカルチームと緊密に連携し、日本国内におけるメディカル戦略の実行を担います。</span></span><span class="LineBreakBlob BlobObject DragDrop SCXW99903740 BCX8"><span class="SCXW99903740 BCX8"> </span><br class="SCXW99903740 BCX8"></span><span class="TextRun SCXW99903740 BCX8" lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW99903740 BCX8">Key Opinion </span><span class="NormalTextRun SpellingErrorV2Themed SCXW99903740 BCX8">Leader</span><span class="NormalTextRun SpellingErrorV2Themed SCXW99903740 BCX8">(</span><span class="NormalTextRun SpellingErrorV2Themed SCXW99903740 BCX8">KOL</span></span><span class="TextRun SCXW99903740 BCX8" lang="JA-JP" data-contrast="auto"><span class="NormalTextRun SCXW99903740 BCX8">)や主要医療機関</span><span class="NormalTextRun SCXW99903740 BCX8">へ</span><span class="NormalTextRun SCXW99903740 BCX8">の</span><span class="NormalTextRun SCXW99903740 BCX8">サイエンス</span><span class="NormalTextRun SCXW99903740 BCX8">ベースの関係構築、最新科学情報の提供、エンゲージメントを通じ、</span></span><span class="TextRun SCXW99903740 BCX8" lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW99903740 BCX8">Ultragenyx</span></span><span class="TextRun SCXW99903740 BCX8" lang="JA-JP" data-contrast="auto"><span class="NormalTextRun SCXW99903740 BCX8">の開発品および上市製品の医療的価値</span><span class="NormalTextRun SCXW99903740 BCX8">の最大化</span><span class="NormalTextRun SCXW99903740 BCX8">を支援します。</span></span><span class="LineBreakBlob BlobObject DragDrop SCXW99903740 BCX8"><span class="SCXW99903740 BCX8"> </span><br class="SCXW99903740 BCX8"></span><span cl ... (truncated, view full listing at source)